Parkside Financial Bank & Trust Dyne Therapeutics, Inc. Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 80 shares of DYN stock, worth $946. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80Holding current value
$946% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
100MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$94.9 Million31.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$87.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$87.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$87.3 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$75.5 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $612M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...